{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:52:49Z","timestamp":1787032369614,"version":"build-2736575974"},"reference-count":92,"publisher":"Harborside Press, LLC","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:p>Hepatosplenic T-cell lymphoma (HSTCL) is a rare subtype of T-cell lymphoma associated with an aggressive clinical course and a worse prognosis. HSTCL develops in the setting of chronic immune suppression or immune dysregulation in up to 20% of cases and is most often characterized by spleen, liver, and bone marrow involvement. Diagnosis and management of HSTCL pose significant challenges given the rarity of the disease along with the absence of lymphadenopathy and poor outcome with conventional chemotherapy regimens. These Guidelines Insights focus on the diagnosis and treatment of HSTCL as outlined in the NCCN Guidelines for T-Cell Lymphomas.<\/jats:p>","DOI":"10.6004\/jnccn.2020.0053","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T15:24:08Z","timestamp":1604589848000},"page":"1460-1467","source":"Crossref","is-referenced-by-count":43,"title":["NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021"],"prefix":"10.6004","volume":"18","author":[{"given":"Steven M.","family":"Horwitz","sequence":"first","affiliation":[{"name":"1Memorial Sloan Kettering Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Ansell","sequence":"additional","affiliation":[{"name":"2Mayo Clinic Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyun Z.","family":"Ai","sequence":"additional","affiliation":[{"name":"3UCSF Helen Diller Family Comprehensive Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Barnes","sequence":"additional","affiliation":[{"name":"4Massachusetts General Hospital Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan K.","family":"Barta","sequence":"additional","affiliation":[{"name":"5Abramson Cancer Center at the University of Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Clemens","sequence":"additional","affiliation":[{"name":"6The University of Texas MD Anderson Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Dogan","sequence":"additional","affiliation":[{"name":"1Memorial Sloan Kettering Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron M.","family":"Goodman","sequence":"additional","affiliation":[{"name":"7UC San Diego Moores Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Goyal","sequence":"additional","affiliation":[{"name":"8O'Neal Comprehensive Cancer Center at UAB;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Guitart","sequence":"additional","affiliation":[{"name":"9Robert H. Lurie Comprehensive Cancer Center of Northwestern University;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Halwani","sequence":"additional","affiliation":[{"name":"10Huntsman Cancer Institute at the University of Utah;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley M.","family":"Haverkos","sequence":"additional","affiliation":[{"name":"11University of Colorado Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Hoppe","sequence":"additional","affiliation":[{"name":"12Stanford Cancer Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Jacobsen","sequence":"additional","affiliation":[{"name":"13Dana-Farber\/Brigham and Women's Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Jagadeesh","sequence":"additional","affiliation":[{"name":"14Case Comprehensive Cancer Center\/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Jones","sequence":"additional","affiliation":[{"name":"15St. Jude Children's Research Hospital\/The University of Tennessee Health Science Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youn H.","family":"Kim","sequence":"additional","affiliation":[{"name":"12Stanford Cancer Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Mehta-Shah","sequence":"additional","affiliation":[{"name":"16Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise A.","family":"Olsen","sequence":"additional","affiliation":[{"name":"17Duke Cancer Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Pro","sequence":"additional","affiliation":[{"name":"9Robert H. Lurie Comprehensive Cancer Center of Northwestern University;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh A.","family":"Rajguru","sequence":"additional","affiliation":[{"name":"18University of Wisconsin Carbone Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Rozati","sequence":"additional","affiliation":[{"name":"19The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Said","sequence":"additional","affiliation":[{"name":"20UCLA Jonsson Comprehensive Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Shaver","sequence":"additional","affiliation":[{"name":"21Vanderbilt-Ingram Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Shustov","sequence":"additional","affiliation":[{"name":"22Fred Hutchinson Cancer Research Center\/Seattle Cancer Care Alliance;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubomir","family":"Sokol","sequence":"additional","affiliation":[{"name":"23Moffitt Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallawi","family":"Torka","sequence":"additional","affiliation":[{"name":"24Roswell Park Comprehensive Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Torres-Cabala","sequence":"additional","affiliation":[{"name":"6The University of Texas MD Anderson Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Wilcox","sequence":"additional","affiliation":[{"name":"25University of Michigan Rogel Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basem M.","family":"William","sequence":"additional","affiliation":[{"name":"26The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Zain","sequence":"additional","affiliation":[{"name":"27City of Hope National Medical Center; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary A.","family":"Dwyer","sequence":"additional","affiliation":[{"name":"28National Comprehensive Cancer Network."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hema","family":"Sundar","sequence":"additional","affiliation":[{"name":"28National Comprehensive Cancer Network."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4047","reference":[{"key":"ref191","doi-asserted-by":"crossref","first-page":"e102977","DOI":"10.1371\/journal.pone.0102977","article-title":"Integrative genomic and transcriptomic analysis identified candidate genes implicated in the pathogenesis of hepatosplenic T-cell lymphoma","volume":"9","author":"Finalet Ferreiro","year":"2014","journal-title":"PLoS One"},{"key":"ref541","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood.V75.11.2213.2213","article-title":"Hepatosplenic T-cell lymphoma: sinusal\/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta","volume":"75","author":"Farcet","year":"1990","journal-title":"Blood"},{"key":"ref791","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clml.2012.09.002","article-title":"Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience","volume":"13","author":"Voss","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1002\/cncr.30826","article-title":"A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults","volume":"123","author":"Daver","year":"2017","journal-title":"Cancer"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/00000478-200007000-00016","article-title":"Hepatosplenic alphabeta T-cell lymphoma: an unusual case with clinical, histologic, and cytogenetic features of gammadelta hepatosplenic T-cell lymphoma","volume":"24","author":"Suarez","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"ref601","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1182\/blood.V88.11.4265.bloodjournal88114265","article-title":"Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin","volume":"88","author":"Cooke","year":"1996","journal-title":"Blood"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/annonc\/mdn751","article-title":"Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment","volume":"20","author":"Falchook","year":"2009","journal-title":"Ann Oncol"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/PAS.0000000000000743","article-title":"Distinguishing between hepatosplenic T-cell lymphoma and \u03b3\u03b4 T-cell large granular lymphocytic leukemia: a clinicopathologic, immunophenotypic, and molecular analysis","volume":"41","author":"Yabe","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/01.mph.0000187431.37369.f5","article-title":"Allogeneic bone marrow transplantation for chemotherapy-refractory hepatosplenic gammadelta T-cell lymphoma: case report and review of the literature","volume":"27","author":"Domm","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.anndiagpath.2016.10.005","article-title":"Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor-\u03b1 inhibitor therapy and literature review","volume":"26","author":"Yabe","year":"2017","journal-title":"Ann Diagn Pathol"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/PAS.0000000000000614","article-title":"Prognostic factors of hepatosplenic T-cell lymphoma: clinicopathologic study of 28 cases","volume":"40","author":"Yabe","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"ref901","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3109\/10428194.2014.947613","article-title":"Successful treatment with reduced-intensity cord blood transplant in a patient with relapsed refractory hepatosplenic T-cell lymphoma","volume":"56","author":"Sumi","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"ref631","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/sj.leu.2400742","article-title":"Isochromosome 7q: the primary cytogenetic abnormality in hepatosplenic gammadelta T cell lymphoma","volume":"11","author":"Alonsozana","year":"1997","journal-title":"Leukemia"},{"key":"ref481","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/ajcp\/aqw213","article-title":"T- and NK-cell lymphomas and systemic lymphoproliferative disorders and the immunodeficiency setting: 2015 SH\/EAHP workshop report\u2013part 4","volume":"147","author":"Gratzinger","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"ref451","doi-asserted-by":"crossref","first-page":"e12941","DOI":"10.1097\/MD.0000000000012941","article-title":"Successful second allogeneic stem-cell transplantation from the same sibling donor for a patient with recurrent hepatosplenic gamma-delta (\u03b3\/\u03b4) T-cell lymphoma: a case report","volume":"97","author":"Pan","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"ref511","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.anndiagpath.2016.10.005","article-title":"Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor-\u03b1 inhibitor therapy and literature review","volume":"26","author":"Yabe","year":"2017","journal-title":"Ann Diagn Pathol"},{"key":"ref731","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/PAS.0000000000000743","article-title":"Distinguishing between hepatosplenic T-cell lymphoma and \u03b3\u03b4 T-cell large granular lymphocytic leukemia: a clinicopathologic, immunophenotypic, and molecular analysis","volume":"41","author":"Yabe","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/annonc\/mdn119","article-title":"Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine","volume":"19","author":"Jaeger","year":"2008","journal-title":"Ann Oncol"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/leu.2014.280","article-title":"Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party","volume":"29","author":"Tanase","year":"2015","journal-title":"Leukemia"},{"key":"ref771","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2003-05-1675","article-title":"Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients","volume":"102","author":"Belhadj","year":"2003","journal-title":"Blood"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/gcc.2870120302","article-title":"Consistent presence of isochromosome 7q in hepatosplenic T gamma\/delta lymphoma: a new cytogenetic-clinicopathologic entity","volume":"12","author":"Wang","year":"1995","journal-title":"Genes Chromosomes Cancer"},{"key":"ref301","first-page":"137","article-title":"18F-FDG PET\/CT findings in hepatosplenic gamma-delta T-cell lymphoma: case reports and review of the literature","volume":"8","author":"Cho","year":"2018","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"ref591","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.5858\/arpa.2014-0079-RS","article-title":"Hepatosplenic T-cell lymphoma: a clinicopathologic review with an emphasis on diagnostic differentiation from other T-cell\/natural killer-cell neoplasms","volume":"139","author":"Shi","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"ref881","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/leu.2014.280","article-title":"Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party","volume":"29","author":"Tanase","year":"2015","journal-title":"Leukemia"},{"key":"ref841","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/annonc\/mdn119","article-title":"Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine","volume":"19","author":"Jaeger","year":"2008","journal-title":"Ann Oncol"},{"key":"ref861","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/ajh.21774","article-title":"Hepatosplenic T cell lymphoma responsive to 2\u2032-deoxycoformycin therapy","volume":"85","author":"Bennett","year":"2010","journal-title":"Am J Hematol"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00000478-200103000-00002","article-title":"Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas","volume":"25","author":"Macon","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/ajcp\/aqw213","article-title":"T- and NK-cell lymphomas and systemic lymphoproliferative disorders and the immunodeficiency setting: 2015 SH\/EAHP workshop report\u2013part 4","volume":"147","author":"Gratzinger","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/MEG.0b013e32834bb90a","article-title":"Hepatosplenic T-cell lymphoma in patients receiving TNF-\u03b1 inhibitor therapy: expanding the groups at risk","volume":"23","author":"Parakkal","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref351","first-page":"519","article-title":"Hepatosplenic gamma delta T-cell lymphoma with leukemic phase successfully treated with 2-chlorodeoxyadenosine","volume":"32","author":"Gopcsa","year":"2002","journal-title":"Haematologia (Budap)"},{"key":"ref741","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V106.11.4343.4343","article-title":"Ehrlichiosis mimicking T-cell lymphoma\/leukemia [abstract]","volume":"106","author":"Malani","year":"2005","journal-title":"Blood"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.humpath.2018.01.005","article-title":"Hepatosplenic T-cell lymphoma: a review of clinicopathologic features, pathogenesis, and prognostic factors","volume":"74","author":"Yabe","year":"2018","journal-title":"Hum Pathol"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3960\/jslrt.56.160","article-title":"Cytopenias and clonal expansion of gamma\/delta T-cells in a patient with anaplasmosis: a potential diagnostic pitfall","volume":"56","author":"Marko","year":"2017","journal-title":"J Clin Exp Hematop"},{"key":"ref621","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3109\/10428199609054788","article-title":"Clinical and hematological characteristics of hepatosplenic T gamma\/delta lymphoma with isochromosome for long arm of chromosome 7","volume":"22","author":"Yao","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"ref671","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1038\/leu.2014.200","article-title":"Frequent STAT5B mutations in \u03b3\u03b4 hepatosplenic T-cell lymphomas","volume":"28","author":"Nicolae","year":"2014","journal-title":"Leukemia"},{"key":"ref871","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.1038\/bcj.2015.43","article-title":"Outcomes of allogeneic stem cell transplantation in hepatosplenic T-cell lymphoma","volume":"5","author":"Rashidi","year":"2015","journal-title":"Blood Cancer J"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/ajh.25674","article-title":"Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas","volume":"95","author":"Foss","year":"2020","journal-title":"Am J Hematol"},{"key":"ref521","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1002\/cncr.30826","article-title":"A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults","volume":"123","author":"Daver","year":"2017","journal-title":"Cancer"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.clml.2019.10.007","article-title":"Intensive induction therapy compared with CHOP for hepatosplenic T-cell lymphoma","volume":"20","author":"Klebaner","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1038\/leu.2014.200","article-title":"Frequent STAT5B mutations in \u03b3\u03b4 hepatosplenic T-cell lymphomas","volume":"28","author":"Nicolae","year":"2014","journal-title":"Leukemia"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1182\/blood.V88.11.4265.bloodjournal88114265","article-title":"Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin","volume":"88","author":"Cooke","year":"1996","journal-title":"Blood"},{"key":"ref531","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.humpath.2018.01.005","article-title":"Hepatosplenic T-cell lymphoma: a review of clinicopathologic features, pathogenesis, and prognostic factors","volume":"74","author":"Yabe","year":"2018","journal-title":"Hum Pathol"},{"key":"ref611","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/gcc.2870120302","article-title":"Consistent presence of isochromosome 7q in hepatosplenic T gamma\/delta lymphoma: a new cytogenetic-clinicopathologic entity","volume":"12","author":"Wang","year":"1995","journal-title":"Genes Chromosomes Cancer"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2003-05-1675","article-title":"Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients","volume":"102","author":"Belhadj","year":"2003","journal-title":"Blood"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.5858\/arpa.2014-0079-RS","article-title":"Hepatosplenic T-cell lymphoma: a clinicopathologic review with an emphasis on diagnostic differentiation from other T-cell\/natural killer-cell neoplasms","volume":"139","author":"Shi","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"ref911","doi-asserted-by":"crossref","first-page":"e12941","DOI":"10.1097\/MD.0000000000012941","article-title":"Successful second allogeneic stem-cell transplantation from the same sibling donor for a patient with recurrent hepatosplenic gamma-delta (\u03b3\/\u03b4) T-cell lymphoma: a case report","volume":"97","author":"Pan","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"ref801","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.clml.2019.10.007","article-title":"Intensive induction therapy compared with CHOP for hepatosplenic T-cell lymphoma","volume":"20","author":"Klebaner","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref751","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3960\/jslrt.56.160","article-title":"Cytopenias and clonal expansion of gamma\/delta T-cells in a patient with anaplasmosis: a potential diagnostic pitfall","volume":"56","author":"Marko","year":"2017","journal-title":"J Clin Exp Hematop"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood.V75.11.2213.2213","article-title":"Hepatosplenic T-cell lymphoma: sinusal\/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta","volume":"75","author":"Farcet","year":"1990","journal-title":"Blood"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1182\/blood-2011-12-396150","article-title":"Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets","volume":"119","author":"Travert","year":"2012","journal-title":"Blood"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3109\/10428199609054788","article-title":"Clinical and hematological characteristics of hepatosplenic T gamma\/delta lymphoma with isochromosome for long arm of chromosome 7","volume":"22","author":"Yao","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"ref571","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00000478-200103000-00002","article-title":"Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas","volume":"25","author":"Macon","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1200\/JCO.2009.22.6688","article-title":"Phase II study of alemtuzumab in combination with pentostatin in patients with T-cell neoplasms","volume":"27","author":"Ravandi","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref561","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/00000478-200007000-00016","article-title":"Hepatosplenic alphabeta T-cell lymphoma: an unusual case with clinical, histologic, and cytogenetic features of gammadelta hepatosplenic T-cell lymphoma","volume":"24","author":"Suarez","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"ref851","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1200\/JCO.2009.22.6688","article-title":"Phase II study of alemtuzumab in combination with pentostatin in patients with T-cell neoplasms","volume":"27","author":"Ravandi","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref281","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V106.11.4343.4343","article-title":"Ehrlichiosis mimicking T-cell lymphoma\/leukemia [abstract]","volume":"106","author":"Malani","year":"2005","journal-title":"Blood"},{"key":"ref551","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/sj.leu.2401784","article-title":"Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990","volume":"14","author":"Weidmann","year":"2000","journal-title":"Leukemia"},{"key":"ref721","doi-asserted-by":"crossref","first-page":"e387","DOI":"10.3324\/haematol.2016.146118","article-title":"Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma","volume":"101","author":"Blombery","year":"2016","journal-title":"Haematologica"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3109\/10428194.2014.947613","article-title":"Successful treatment with reduced-intensity cord blood transplant in a patient with relapsed refractory hepatosplenic T-cell lymphoma","volume":"56","author":"Sumi","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"ref401","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/ajh.21774","article-title":"Hepatosplenic T cell lymphoma responsive to 2\u2032-deoxycoformycin therapy","volume":"85","author":"Bennett","year":"2010","journal-title":"Am J Hematol"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1046\/j.1365-2141.2002.03537_3.x","article-title":"Hepatosplenic gammadelta T-cell lymphoma: complete response induced by treatment with pentostatin","volume":"117","author":"Iannitto","year":"2002","journal-title":"Br J Haematol"},{"key":"ref461","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2017"},{"key":"ref661","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1182\/blood-2011-12-396150","article-title":"Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets","volume":"119","author":"Travert","year":"2012","journal-title":"Blood"},{"key":"ref371","first-page":"ECR14","article-title":"Pentostatin (2\u2032-deoxycoformycin) for the treatment of hepatosplenic gammadelta T-cell lymphomas","volume":"90","author":"Corazzelli","year":"2005","journal-title":"Haematologica"},{"key":"ref01","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2017"},{"key":"ref651","doi-asserted-by":"crossref","first-page":"e102977","DOI":"10.1371\/journal.pone.0102977","article-title":"Integrative genomic and transcriptomic analysis identified candidate genes implicated in the pathogenesis of hepatosplenic T-cell lymphoma","volume":"9","author":"Finalet Ferreiro","year":"2014","journal-title":"PLoS One"},{"key":"ref781","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/annonc\/mdn751","article-title":"Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment","volume":"20","author":"Falchook","year":"2009","journal-title":"Ann Oncol"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"e387","DOI":"10.3324\/haematol.2016.146118","article-title":"Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma","volume":"101","author":"Blombery","year":"2016","journal-title":"Haematologica"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/sj.leu.2401784","article-title":"Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990","volume":"14","author":"Weidmann","year":"2000","journal-title":"Leukemia"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1114885","article-title":"Somatic STAT3 mutations in large granular lymphocytic leukemia","volume":"366","author":"Koskela","year":"2012","journal-title":"N Engl J Med"},{"key":"ref831","first-page":"ECR14","article-title":"Pentostatin (2\u2032-deoxycoformycin) for the treatment of hepatosplenic gammadelta T-cell lymphomas","volume":"90","author":"Corazzelli","year":"2005","journal-title":"Haematologica"},{"key":"ref491","first-page":"blood.2019004118","article-title":"Hepatosplenic T-cell lymphoma: a rare but challenging entity","author":"Pro","year":"2020","journal-title":"Blood"},{"key":"ref681","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/2159-8290.CD-16-0330","article-title":"The genetic basis of hepatosplenic T-cell lymphoma","volume":"7","author":"McKinney","year":"2017","journal-title":"Cancer Discov"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1038\/leu.2013.104","article-title":"STAT3 mutations are frequent in CD30+ T-cell lymphomas and T-cell large granular lymphocytic leukemia","volume":"27","author":"Ohgami","year":"2013","journal-title":"Leukemia"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/ajh.25674","article-title":"Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas","volume":"95","author":"Foss","year":"2020","journal-title":"Am J Hematol"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/sj.leu.2400742","article-title":"Isochromosome 7q: the primary cytogenetic abnormality in hepatosplenic gammadelta T cell lymphoma","volume":"11","author":"Alonsozana","year":"1997","journal-title":"Leukemia"},{"key":"ref811","first-page":"519","article-title":"Hepatosplenic gamma delta T-cell lymphoma with leukemic phase successfully treated with 2-chlorodeoxyadenosine","volume":"32","author":"Gopcsa","year":"2002","journal-title":"Haematologia (Budap)"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/MEG.0b013e32834bb90a","article-title":"Hepatosplenic T-cell lymphoma in patients receiving TNF-\u03b1 inhibitor therapy: expanding the groups at risk","volume":"23","author":"Parakkal","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref691","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1182\/blood-2012-06-435297","article-title":"STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia","volume":"120","author":"Jerez","year":"2012","journal-title":"Blood"},{"key":"ref581","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/PAS.0000000000000614","article-title":"Prognostic factors of hepatosplenic T-cell lymphoma: clinicopathologic study of 28 cases","volume":"40","author":"Yabe","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"ref31","first-page":"blood.2019004118","article-title":"Hepatosplenic T-cell lymphoma: a rare but challenging entity","author":"Pro","year":"2020","journal-title":"Blood"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/2159-8290.CD-16-0330","article-title":"The genetic basis of hepatosplenic T-cell lymphoma","volume":"7","author":"McKinney","year":"2017","journal-title":"Cancer Discov"},{"key":"ref641","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/gcc.10021","article-title":"Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma: isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression","volume":"33","author":"Wlodarska","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"ref891","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/01.mph.0000187431.37369.f5","article-title":"Allogeneic bone marrow transplantation for chemotherapy-refractory hepatosplenic gammadelta T-cell lymphoma: case report and review of the literature","volume":"27","author":"Domm","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/gcc.10021","article-title":"Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma: isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression","volume":"33","author":"Wlodarska","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"ref761","first-page":"137","article-title":"18F-FDG PET\/CT findings in hepatosplenic gamma-delta T-cell lymphoma: case reports and review of the literature","volume":"8","author":"Cho","year":"2018","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"ref701","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1114885","article-title":"Somatic STAT3 mutations in large granular lymphocytic leukemia","volume":"366","author":"Koskela","year":"2012","journal-title":"N Engl J Med"},{"key":"ref821","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1046\/j.1365-2141.2002.03537_3.x","article-title":"Hepatosplenic gammadelta T-cell lymphoma: complete response induced by treatment with pentostatin","volume":"117","author":"Iannitto","year":"2002","journal-title":"Br J Haematol"},{"key":"ref711","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1038\/leu.2013.104","article-title":"STAT3 mutations are frequent in CD30+ T-cell lymphomas and T-cell large granular lymphocytic leukemia","volume":"27","author":"Ohgami","year":"2013","journal-title":"Leukemia"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1182\/blood-2012-06-435297","article-title":"STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia","volume":"120","author":"Jerez","year":"2012","journal-title":"Blood"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clml.2012.09.002","article-title":"Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience","volume":"13","author":"Voss","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.1038\/bcj.2015.43","article-title":"Outcomes of allogeneic stem cell transplantation in hepatosplenic T-cell lymphoma","volume":"5","author":"Rashidi","year":"2015","journal-title":"Blood Cancer J"}],"container-title":["Journal of the National Comprehensive Cancer Network"],"original-title":[],"link":[{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/18\/11\/article-p1460.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/18\/11\/article-p1460.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T13:13:57Z","timestamp":1608902037000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/18\/11\/article-p1460.xml"}},"subtitle":["Featured Updates to the NCCN Guidelines"],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":92,"journal-issue":{"issue":"11"},"URL":"https:\/\/doi.org\/10.6004\/jnccn.2020.0053","relation":{},"ISSN":["1540-1405","1540-1413"],"issn-type":[{"value":"1540-1405","type":"print"},{"value":"1540-1413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11]]}}}